Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.610
-0.010 (-0.38%)
At close: Dec 20, 2024, 4:00 PM
2.660
+0.050 (1.92%)
After-hours: Dec 20, 2024, 7:16 PM EST

Lipella Pharmaceuticals Revenue

Lipella Pharmaceuticals had revenue of $80.38K in the quarter ending September 30, 2024, a decrease of -22.75%. This brings the company's revenue in the last twelve months to $483.53K, up 0.78% year-over-year. In the year 2023, Lipella Pharmaceuticals had annual revenue of $449.62K with 144.15% growth.

Revenue (ttm)
$483.53K
Revenue Growth
+0.78%
P/S Ratio
5.17
Revenue / Employee
$69,076
Employees
7
Market Cap
3.16M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023449.62K265.46K144.15%
Dec 31, 2022184.16K-75.19K-28.99%
Dec 31, 2021259.35K-702.34K-73.03%
Dec 31, 2020961.68K266.94K38.42%
Dec 31, 2019694.75K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
iCoreConnect 11.05M
ReShape Lifesciences 8.18M
China Pharma Holdings 5.54M
Petros Pharmaceuticals 4.02M
Mainz Biomed 917.20K
Revenue Rankings